Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

David Peereboom, MD

216.636.0007

David Peereboom, MD
Department: Brain Tumor and Neuro-Oncology Center
Director, Clinical Research
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.636.0007
DeskDesk:216.445.6068
WorkFax:216.444.9464
David Peereboom, MD
Department: Hematology and Oncology
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6833
DeskDesk:216.445.6068
WorkFax:216.444.9464
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

As a Staff Member of the Cleveland Clinic’s Rose Ella Burkhardt Brain tumor and Neuro-Oncology Center, and Staff Physician of the Cleveland Clinic Taussig Cancer Center, David Peereboom, MD, is a medical oncologist specializing in the management of brain tumors.

A graduate of the Virginia Commonwealth University Medical College in Richmond, Va., Dr. Peereboom received his specialty training at University Hospitals of Cleveland and the Johns Hopkins Oncology Center in Baltimore. His specialty interests include neuro-oncology and experimental therapeutics.

Education & Fellowships

Fellowship - Johns Hopkins Hospital
Oncology
Baltimore, MD USA
1993
Residency - University Hospitals of Cleveland
Internal Medicine
Cleveland, OH USA
1989
Internship - University Hospitals of Cleveland
Medicine
Cleveland, OH USA
1987
Medical School - Virginia Commonwealth University Medical College
Richmond, VA USA
1986

Certifications

  • Internal Medicine- Medical Oncology
  • Internal Medicine

Specialty Interests

Benign and malignant tumors of the brain and spinal cord, benign brain tumors (meningiomas, schwannomas), brain metastases, brain tumors, CNS metastatic disease, experimental therapeutics, molecular biology of brain tumors, clinical and translational trials, neuro-oncology, tumors of the brain and spine, cancer

Awards & Honors

America's Best Doctors

Memberships

  • Society for Neuro Oncology
  • American Society of Clinical Oncology

Treatment & Services

  • Brain Tumor Diagnosis
  • Brain Tumor Management
  • Chemotherapy
  • Clinical Trials
  • Experimental Therapeutics
  • Neuro-Oncology

Specialty in Diseases and Conditions

  • Adult Brain Tumors
  • Anaplastic Astrocytomas
  • Anaplastic Oligodendrogliomas
  • Astrocytoma
  • Brain Cancer (Brain Tumor)
  • Brain Lymphoma
  • Brain Metastases
  • Cancer
  • Glioblastoma Multiforme
  • Malignant Gliomas
  • Malignant Tumors of the Brain
  • Malignant Tumors of the Spinal Cord
  • Metastatic Cancer
  • Oligodendroglioma
  • Primary Central Nervous System Lymphomas
  • Sarcomas of the Brain or Head

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/18/2014, Dr. Peereboom has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English